Journal articles on the topic 'Pharmacokinetic interactions'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Pharmacokinetic interactions.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Taylor, David. "Pharmacokinetic interactions involving clozapine." British Journal of Psychiatry 171, no. 2 (August 1997): 109–12. http://dx.doi.org/10.1192/bjp.171.2.109.
Keirns, J., T. Sawamoto, M. Holum, D. Buell, W. Wisemandle, and A. Alak. "Steady-State Pharmacokinetics of Micafungin and Voriconazole after Separate and Concomitant Dosing in Healthy Adults." Antimicrobial Agents and Chemotherapy 51, no. 2 (November 20, 2006): 787–90. http://dx.doi.org/10.1128/aac.00673-06.
Soyata, Amelia, Aliya Nur Hasanah, and Taofik Rusdiana. "Interaction of Warfarin with Herbs Based on Pharmacokinetic and Pharmacodynamic Parameters." Indonesian Journal of Pharmaceutics 2, no. 2 (June 5, 2020): 69. http://dx.doi.org/10.24198/idjp.v2i2.27289.
Costache, Irina-Iuliana, Anca Miron, Monica Hăncianu, Viviana Aursulesei, Alexandru Dan Costache, and Ana Clara Aprotosoaie. "Pharmacokinetic Interactions between Cardiovascular Medicines and Plant Products." Cardiovascular Therapeutics 2019 (September 2, 2019): 1–19. http://dx.doi.org/10.1155/2019/9402781.
ERESHEFSKY, LARRY, STEPHEN R. SAKLAD, MARK D. WATANABE, CHESTER M. DAVIS, and MICHAEL W. JANN. "Thiothixene Pharmacokinetic Interactions." Journal of Clinical Psychopharmacology 11, no. 5 (October 1991): 296???301. http://dx.doi.org/10.1097/00004714-199110000-00004.
Hartshorn, Edward A. "Pharmacokinetic Drug Interactions." Journal of Pharmacy Technology 1, no. 5 (September 1985): 193–99. http://dx.doi.org/10.1177/875512258500100505.
Eichelbaum, Michel. "Pharmacokinetic Drug Interactions." Journal of Clinical Pharmacology 26, no. 6 (July 8, 1986): 469–73. http://dx.doi.org/10.1002/j.1552-4604.1986.tb03560.x.
Pukrittayakamee, Sasithon, Joel Tarning, Podjanee Jittamala, Prakaykaew Charunwatthana, Saranath Lawpoolsri, Sue J. Lee, Warunee Hanpithakpong, et al. "Pharmacokinetic Interactions between Primaquine and Chloroquine." Antimicrobial Agents and Chemotherapy 58, no. 6 (March 31, 2014): 3354–59. http://dx.doi.org/10.1128/aac.02794-13.
Cohen, Lawrence J., and C. Lindsay DeVane. "Clinical Implications of Antidepressant Pharmacokinetics and Pharmacogenetics." Annals of Pharmacotherapy 30, no. 12 (December 1996): 1471–80. http://dx.doi.org/10.1177/106002809603001216.
Marvanova, Marketa. "Pharmacokinetic characteristics of antiepileptic drugs (AEDs)." Mental Health Clinician 6, no. 1 (January 1, 2016): 8–20. http://dx.doi.org/10.9740/mhc.2015.01.008.
Rodin, Steven M., and Brian F. Johnson. "Pharmacokinetic Interactions with Digoxin." Clinical Pharmacokinetics 15, no. 4 (October 1988): 227–44. http://dx.doi.org/10.2165/00003088-198815040-00003.
Glue, Paul, Christopher R. Banfield, James L. Perhach, Gary G. Mather, Jagdish K. Racha, and Rene H. Levy. "Pharmacokinetic Interactions with Felbamate." Clinical Pharmacokinetics 33, no. 3 (September 1997): 214–24. http://dx.doi.org/10.2165/00003088-199733030-00004.
Niemi, Mikko, Janne T. Backman, Martin F. Fromm, Pertti J. Neuvonen, and Kari T. Kivist?? "Pharmacokinetic Interactions with Rifampicin." Clinical Pharmacokinetics 42, no. 9 (2003): 819–50. http://dx.doi.org/10.2165/00003088-200342090-00003.
Bialer, Meir, Dennis R. Doose, Bindu Murthy, Christopher Curtin, Shean-Sheng Wang, Roy E. Twyman, and Stefan Schwabe. "Pharmacokinetic Interactions of Topiramate." Clinical Pharmacokinetics 43, no. 12 (2004): 763–80. http://dx.doi.org/10.2165/00003088-200443120-00001.
Scheen, Andr?? J. "Pharmacokinetic Interactions with Thiazolidinediones." Clinical Pharmacokinetics 46, no. 1 (2007): 1–12. http://dx.doi.org/10.2165/00003088-200746010-00001.
&NA;. "Olanzapine + fluvoxamine: pharmacokinetic interactions." Inpharma Weekly &NA;, no. 1362 (November 2002): 20. http://dx.doi.org/10.2165/00128413-200213620-00050.
Reinoso, R. F., A. Sánchez Navarro, M. J. García, and J. R. Prous. "Pharmacokinetic interactions of statins." Methods and Findings in Experimental and Clinical Pharmacology 23, no. 10 (2001): 541. http://dx.doi.org/10.1358/mf.2001.23.10.677120.
Baciewicz, Anne M., and Frank A. Baciewicz. "Cyclosporine pharmacokinetic drug interactions." American Journal of Surgery 157, no. 2 (February 1989): 264–71. http://dx.doi.org/10.1016/0002-9610(89)90541-2.
Kalam, Muhammad Nasir, Muhammad Fawad Rasool, Asim Ur Rehman, and Naveed Ahmed. "Clinical Pharmacokinetics of Propranolol Hydrochloride: A Review." Current Drug Metabolism 21, no. 2 (June 11, 2020): 89–105. http://dx.doi.org/10.2174/1389200221666200414094644.
Ahmane, Amel, Hocine Gacem, Karim Boulesbiaat, and Meriem Boullelli. "Pharmacokinetic interactions: from mechanisms to clinical relevance." Batna Journal of Medical Sciences (BJMS) 1, no. 2 (December 31, 2014): 85–95. http://dx.doi.org/10.48087/bjmstf.2014.1209.
Goswami, Suchandra, Shivangi Saxena, Shalini Yadav, Diptendu Goswami, Koushik Brahmachari, Sruti Karmakar, Biswajit Pramanik, and Sunil Brahmachari. "Review of Curcumin and Its Different Formulations: Pharmacokinetics, Pharmacodynamics and Pharmacokinetic-Pharmacodynamic Interactions." OBM Integrative and Complementary Medicine 07, no. 04 (December 27, 2022): 1–35. http://dx.doi.org/10.21926/obm.icm.2204057.
Liang, Liuyi, Xin Jin, Jinjing Li, Rong Li, Xinyi Jiao, Yuanyuan Ma, Rui Liu, and Zheng Li. "A Comprehensive Review of Pharmacokinetics and Pharmacodynamics in Animals: Exploration of Interaction with Antibiotics of Shuang-Huang- Lian Preparations." Current Topics in Medicinal Chemistry 22, no. 2 (February 2022): 83–94. http://dx.doi.org/10.2174/1568026621666211012111442.
Czyrski, Andrzej, Matylda Resztak, Paweł Świderski, Jan Brylak, and Franciszek K. Główka. "The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles." Pharmaceutics 13, no. 11 (November 19, 2021): 1961. http://dx.doi.org/10.3390/pharmaceutics13111961.
Botts, Sheila R., and Cara Alfaro. "Antidepressant Drug Interactions." Journal of Pharmacy Practice 14, no. 6 (December 2001): 467–77. http://dx.doi.org/10.1177/089719001129040964.
Lesko, L. J. "Pharmacokinetic Drug Interactions with Amiodarone." Clinical Pharmacokinetics 17, no. 2 (August 1989): 130–40. http://dx.doi.org/10.2165/00003088-198917020-00005.
Venkatesan, K. "Pharmacokinetic Drug Interactions with Rifampicin." Clinical Pharmacokinetics 22, no. 1 (January 1992): 47–65. http://dx.doi.org/10.2165/00003088-199222010-00005.
Periti, Piero, Teresita Mazzei, Enrico Mini, and Andrea Novelli. "Pharmacokinetic Drug Interactions of Macrolides." Clinical Pharmacokinetics 23, no. 2 (August 1992): 106–31. http://dx.doi.org/10.2165/00003088-199223020-00004.
Riva, Roberto, Fiorenzo Albani, Manuela Contin, and Agostino Baruzzi. "Pharmacokinetic Interactions Between Antiepileptic Drugs." Clinical Pharmacokinetics 31, no. 6 (December 1996): 470–93. http://dx.doi.org/10.2165/00003088-199631060-00005.
Giao, Phantrong, and Peter J. de Vries. "Pharmacokinetic Interactions of Antimalarial Agents." Clinical Pharmacokinetics 40, no. 5 (2001): 343–73. http://dx.doi.org/10.2165/00003088-200140050-00003.
Unger, Matthias. "Pharmacokinetic drug interactions involvingGinkgo biloba." Drug Metabolism Reviews 45, no. 3 (July 19, 2013): 353–85. http://dx.doi.org/10.3109/03602532.2013.815200.
Somogyi, Andrew, and Murray Muirhead. "Pharmacokinetic Interactions of Cimetidine 1987." Clinical Pharmacokinetics 12, no. 5 (May 1987): 321–66. http://dx.doi.org/10.2165/00003088-198712050-00002.
Oesterheld, Jessica R., Scott C. Armstrong, and Kelly L. Cozza. "Ecstasy: Pharmacodynamic and Pharmacokinetic Interactions." Psychosomatics 45, no. 1 (March 2004): 84–87. http://dx.doi.org/10.1176/appi.psy.45.1.84.
Pleuvry, Barbara J. "Pharmacodynamic and pharmacokinetic drug interactions." Anaesthesia & Intensive Care Medicine 6, no. 4 (April 2005): 129–33. http://dx.doi.org/10.1383/anes.6.4.129.63634.
Blei, Andres. "Pharmacokinetic-Hemodynamic Interactions in Cirrhosis." Seminars in Liver Disease 6, no. 04 (November 1986): 299–308. http://dx.doi.org/10.1055/s-2008-1040612.
Back, David, Sara Gibbons, and Saye Khoo. "Pharmacokinetic Drug Interactions with Nevirapine." JAIDS Journal of Acquired Immune Deficiency Syndromes 34 (September 2003): S8—S14. http://dx.doi.org/10.1097/00126334-200309011-00003.
Tarirai, Clemence, Alvaro M. Viljoen, and Josias H. Hamman. "Herb–drug pharmacokinetic interactions reviewed." Expert Opinion on Drug Metabolism & Toxicology 6, no. 12 (November 11, 2010): 1515–38. http://dx.doi.org/10.1517/17425255.2010.529129.
Brüggemann, Roger J. M., Jan-Willem C. Alffenaar, Nicole M. A. Blijlevens, Eliane M. Billaud, Jos G. W. Kosterink, Paul E. Verweij, and David M. Burger. "Pharmacokinetic drug interactions of azoles." Current Fungal Infection Reports 2, no. 1 (March 2008): 20–27. http://dx.doi.org/10.1007/s12281-008-0004-4.
Zerjav, Sylvia, Gordon Tse, and Michael J. W. Scott. "Review of Duloxetine and Venlafaxine in Depression." Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 142, no. 3 (May 2009): 144–52. http://dx.doi.org/10.3821/1913-701x-142.3.144.
Choi, Min-Koo, and Im-Sook Song. "Pharmacokinetic Drug–Drug Interactions and Herb–Drug Interactions." Pharmaceutics 13, no. 5 (April 23, 2021): 610. http://dx.doi.org/10.3390/pharmaceutics13050610.
Rapp, Robert P. "Pharmacokinetics and Pharmacodynamics of Intravenous and Oral Azithromycin: Enhanced Tissue Activity and Minimal Drug Interactions." Annals of Pharmacotherapy 32, no. 7-8 (July 1998): 785–93. http://dx.doi.org/10.1345/aph.17299.
Hofmeister, Craig C., Xiaoxia Yang, Flavia Pichiorri, Ping Chen, Darlene M. Rozewski, Amy J. Johnson, Seungsoo Lee, et al. "Phase I Trial of Lenalidomide and CCI-779 in Patients With Relapsed Multiple Myeloma: Evidence for Lenalidomide–CCI-779 Interaction via P-Glycoprotein." Journal of Clinical Oncology 29, no. 25 (September 1, 2011): 3427–34. http://dx.doi.org/10.1200/jco.2010.32.4962.
Albitar, Orwa, Sabariah Noor Harun, Hadzliana Zainal, Baharudin Ibrahim, and Siti Maisharah Sheikh Ghadzi. "Population Pharmacokinetics of Clozapine: A Systematic Review." BioMed Research International 2020 (January 8, 2020): 1–10. http://dx.doi.org/10.1155/2020/9872936.
Karlina, M. V., V. M. Kosman, V. G. Makarov, M. N. Makarova, S. V. Morozov, E. E. Gushchina, and N. V. Zhuravskaya. "Pharmacokinetic Interactions of Phenosanic Acid with Valproic Acid and Carbamazepine in Dogs." Safety and Risk of Pharmacotherapy 10, no. 4 (December 29, 2022): 420–33. http://dx.doi.org/10.30895/2312-7821-2022-10-4-420-433.
Cattaneo, Dario, Cristina Gervasoni, and Alberto Corona. "The Issue of Pharmacokinetic-Driven Drug-Drug Interactions of Antibiotics: A Narrative Review." Antibiotics 11, no. 10 (October 13, 2022): 1410. http://dx.doi.org/10.3390/antibiotics11101410.
Fuhr, Uwe, Chih-hsuan Hsin, Xia Li, Wafaâ Jabrane, and Fritz Sörgel. "Assessment of Pharmacokinetic Drug–Drug Interactions in Humans: In Vivo Probe Substrates for Drug Metabolism and Drug Transport Revisited." Annual Review of Pharmacology and Toxicology 59, no. 1 (January 6, 2019): 507–36. http://dx.doi.org/10.1146/annurev-pharmtox-010818-021909.
Li, Ying, Yin Wu, Ya-Jing Li, Lu Meng, Cong-Yang Ding, and Zhan-Jun Dong. "Effects of Silymarin on the In Vivo Pharmacokinetics of Simvastatin and Its Active Metabolite in Rats." Molecules 24, no. 9 (April 28, 2019): 1666. http://dx.doi.org/10.3390/molecules24091666.
Hoetdmans, Richard MW. "Pharmacology of Antiretroviral Drugs." Antiviral Therapy 4, no. 3_suppl (April 1, 1998): 29–41. http://dx.doi.org/10.1177/135965359900403s01.
Petrykiv, S., L. De Jonge, and M. Arts. "Interactions between SSRI's and statins: Clinical relevance versus statistical significance." European Psychiatry 41, S1 (April 2017): S757—S758. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1418.
Coelho, Maria Miguel, Carla Fernandes, Fernando Remião, and Maria Elizabeth Tiritan. "Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods." Molecules 26, no. 11 (May 23, 2021): 3113. http://dx.doi.org/10.3390/molecules26113113.
Liu, Mou-Ze, Yue-Li Zhang, Mei-Zi Zeng, Fa-Zhong He, Zhi-Ying Luo, Jian-Quan Luo, Jia-Gen Wen, Xiao-Ping Chen, Hong-Hao Zhou, and Wei Zhang. "Pharmacogenomics and Herb-Drug Interactions: Merge of Future and Tradition." Evidence-Based Complementary and Alternative Medicine 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/321091.